1008562-93-3

Basic information

• Product Name: (S)-tert-butyl 3-(Methoxy(Methyl)carbaMoyl)piperidine-1-carboxylate
• Synonyms: (S)-tert-butyl 3-(Methoxy(Methyl)carbaMoyl)piperidine-1-carboxylate;(S)-3-(N-Methoxy-N-methylcarbamoyl)piperidine-1-carboxylic acid tert-butyl ester
• CAS NO: 1008562-93-3
• Molecular Formula: C₁₃H₂₄N₂O₄
• Molecular Weight: 272.34066
• Mol File: 1008562-93-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 343.8±52.0 °C(Predicted)
• Appearance: /
• Density: 1.106±0.06 g/cm3(Predicted)
• PKA: -2.50±0.40(Predicted)
• CAS DataBase Reference: (S)-tert-butyl 3-(Methoxy(Methyl)carbaMoyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-tert-butyl 3-(Methoxy(Methyl)carbaMoyl)piperidine-1-carboxylate(1008562-93-3)
• EPA Substance Registry System: (S)-tert-butyl 3-(Methoxy(Methyl)carbaMoyl)piperidine-1-carboxylate(1008562-93-3)

Safety Data

• Hazardous Substances Data: 1008562-93-3(Hazardous Substances Data)

Usage

General Description

(S)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate is a chemical compound with the molecular formula C13H25N3O4. It is a piperidine derivative that is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and bioactive molecules. The compound has a tert-butyl ester group, a piperidine ring, and a methoxy(methyl)carbamoyl group, making it a versatile intermediate for the synthesis of diverse compounds. Its structural features make it suitable for the development of potential drug candidates for various therapeutic applications. As a result, (S)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate plays a crucial role in the research and development of new pharmaceuticals.

Upstream product

• 88495-54-9 (3S)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 1117-97-1 N,0-dimethylhydroxylamine 

Downstream Products

• 1008563-06-1 (S)-3-acetyl-piperidine-1-carboxylic acid tert-butyl ester 
• 377780-25-1 tert-butyl (3S)-3-(1-hydroxyethyl)piperidine-1-carboxylate 
• 1235439-55-0 3-(1-amino-ethyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 858643-92-2 tert-butyl 3-acetylpiperidine-1-carboxylate 

Relevant articles and documents

MORPHOLINYLBENZOTRIAZINES FOR USE IN CANCER THERAPY

The invention relates to compounds of the formula (I) in which R1, L and m have the meaning indicated in the claims, and/or physiologically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. The compounds of the formula (I) can be used for the inhibition of serine/threonine protein kinases and for the sensitisation of cancer cells to anticancer agents and/or ionising radiation. The invention also relates to the use of the compounds of the formula (I) in the prophylaxis, therapy or progress control of cancer, tumours, metastases or angiogenesis disorders, in combination with radiotherapy and/or an anticancer agent. The invention furthermore relates to a process for the preparation of the compounds of the formula (I) by reaction of compounds of the formulae (II) and (III) and optionally conversion of a base or acid of the compounds of the formula (I) into a salt thereof.

TREATMENT OF METABOLIC SYNDROME WITH CYCLIC AMIDES

The present application relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables are'as defined in the claims. The present application also relates to the treatment of metabolic syndrome or disorders associated with metabolic syndrome in an affected mammal by administering a compound of formula (I) or a pharmaceutically acceptable salt thereof.